Summary of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2025

Accounting Policies [Abstract]

Schedule of Net Revenue Disaggregated by Product and Region

The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):

	Three Months Ended March 31,				Nine Months Ended March 31,
	2025		2024		2025		2024
U.S., Canada and Latin America
Devices	$	422,660	$	399,281	$	1,221,643	$	1,116,513
Masks and other	326,656		288,191		983,929		878,647
Total U.S., Canada and Latin America	$	749,316	$	687,472	$	2,205,572	$	1,995,160
Combined Europe, Asia and other markets
Devices	$	253,543	$	238,919	$	749,646	$	692,411
Masks and other	127,716		122,632		368,687		342,344
Total Combined Europe, Asia and other markets	$	381,259	$	361,551	$	1,118,333	$	1,034,755
Global revenue
Total Devices	$	676,203	$	638,200	$	1,971,289	$	1,808,924
Total Masks and other	454,372		410,823		1,352,616		1,220,991
Total Sleep and Breathing Health	$	1,130,575	$	1,049,023	$	3,323,905	$	3,029,915
Residential Care Software	161,161		147,957		474,429		432,187
Total	$	1,291,736	$	1,196,980	$	3,798,334	$	3,462,102

Schedule of Contract Balances

The following table summarizes our contract balances (in thousands):

	March 31, 2025		June 30, 2024		Balance sheet caption
Contract assets
Accounts receivable, net	$	907,825	$	837,275	Accounts receivable, net
Unbilled revenue, current	$	51,632	$	38,183	Prepaid expenses and other current assets
Unbilled revenue, non-current	$	14,145	$	18,450	Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current	$	(160,445)	$	(152,554)	Deferred revenue (current liabilities)
Deferred revenue, non-current	$	(151,090)	$	(137,343)	Deferred revenue (non-current liabilities)